Roche Sequencing and Life Science

Archived Roche Sequencing and Life Science News

• India gives Roche Diagnostics the license to conduct coronavirus tests, looks to delay disease progression
• Roche Diagnostics launches first in vitro diagnostic ROS1 immunohistochemistry assay
• Two Roche Diagnostic tests identified as transformative products for rapid uptake
• Roche receives Breakthrough Device Designation from FDA for new Alzheimer's disease assays
• Roche to showcase new solutions for lab innovation at EuroMedLab
• Troponin T test provides possible one hour diagnosis of heart attack
• Roche launches the cobas EGFR Mutation Test v2 for use with either plasma or tumour tissue samples
• Roche establishes strategic alliance with Diagnostic Laboratory Services
• Roche launches new protein melting application for real-time PCR LightCycler 1536 instrument
• Roche, BioMed X partner to develop novel nanomaterial-based biosensors
• Roche announces acquisition of Signature Diagnostics
• FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test
• Two fully automated molecular testing systems for blood and plasma donor screening launched by Roche
• Roche's cobas HPV Test gets FDA approval for first-line primary screening for cervical cancer
• Roche, PSS partner to develop fully automated emulsion PCR instrument for sequencing
• Roche’s cobas 4800 HPV Test receives CE mark
• Roche announces availability of new HIV-1 viral load test in the U.S.
• New test to assess viral load of cytomegalovirus
• FDA clears Roche's automated type-specific herpes tests
• Roche MagNA Pure 96 System's CE certified IVD version launched
• Roche files TnT-hs assay 510(k) submission with FDA for use on laboratory analyzers
• EU's Safety Evaluation Ultimately Replacing Animal Testing initiative tests Roche's xCELLigence system
• Study underscores power of real-time cell monitoring to dissect pluridimensionality of GPCR signaling
• Technoclone, Roche enter strategic alliance to co-develop coagulation assays
• Roche proposes to acquire Illumina for $44.50 per share
• Roche signs agreement to acquire Verum Diagnostica
• Roche establishes strategic alliance with Cedars-Sinai Medical Center
• DexCom signs research and development agreement with Roche
• FDA grants Premarket Approval for Roche's IgM antibody to hepatitis B core antigen assay
• Roche launches LightCycler Nano real-time PCR system in the U.S.
• Roche to sponsor 3rd Annual World MRSA Day
• TJUH adopts new equipment from Roche Diagnostics for laboratory testing services
• Roche Diagnostics terminates sales and distribution agreement with Response
• Roche signs agreement to acquire mtm laboratories
• Merck, Roche partner to develop cancer diagnostic assays
• Roche introduces new Accu-Chek Mobile glucose monitoring device
• Roche's cobas HPV Test receives FDA approval for cervical cancer screening
• Roche introduces new EMR interface for the U.S. Department of VA
• Roche LightCycler 480 PCR System to be used at Koch Institute for advanced cancer research
• Study demonstrates ability of cobas HPV Test to detect HPV-16, HPV-18 genotypes linked to cervical cancer
• Roche receives DOD approval to provide remote service and support for its lab analyzers
• Roche launches new xCELLigence System RTCA HT Instrument
• NT-proBNP guided heart failure care associated with reduced cardiovascular events
• Roche, CapitalBio to initiate strategic partnership for molecular diagnostic applications
• Roche announces U.S. introduction of cobas e 602 analyzer
• Roche, DKFZ announce research collaboration to predict cervical cancer risk
• New RTCA Cardio Instrument monitors real-time cardiomyocyte beating and cellular events
• Roche Diagnostics introduces STAT immunoassays for cardiac biomarker testing
• Roche granted FDA 510(k) clearance for cobas 8000 modular analyzer series
• Roche to present diagnostics testing solutions at 2010 Clinical Lab Expo
• Roche receives FDA 510(k) clearance for CoaguChek XS Pro point-of-care anticoagulation monitor
• Screening for HPV genotypes 16 and 18 helps detect cervical pre-cancer missed by Pap test
• Patient health and safety initiatives to be highlighted at ADA annual conference
• Juvenile Diabetes Research Foundation International honors Roche with "Chancellor's Award"
• Roche launches GS Junior System benchtop DNA sequencing platform for life science research
• FDA grants Premarket Approval for Roche Diagnostics' Elecsys Antibody to hepatitis C virus assay
• Roche Diagnostics, ACC collaborate to develop biomarkers clinical resource Web portal
• Roche launches cobas(R) 4800 System in Canada for testing CT, NG and HPV
• Roche Diagnostics' CoaguChek XS Plus system granted CLIA-waived status
• Roche Diagnostics named sole source supplier for Premier's blood glucose monitoring devices
• Roche Diagnostics and Takara Bio enter into license agreement
• Roche Diagnostics launches new customer training center in Pleasanton, California
• FDA approves additional intended use of Roche's cobas TaqScreen MPX Test
• Roche, Spanish Department of Health to collaborate in Medical Genome Project
• New nucleic acid test to screen donated blood for HIV-1 Group M RNA approved
• SAIC-Frederick and Roche collaborate on technology advancements in sequencing cancer genes
• FDA approves new Roche direct detection of West Nile Virus in donated human blood
• Fast market penetration for Roche HIV viral load monitoring test
• Roche makes offer to acquire Ventana Medical Systems
• Roche to acquire BioVeris
• FDA accepts two Roche diagnostics HPV tests for review